Ajax-Loading

Johnson & Johnson - Total Other Income Expense Net

Johnson & Johnson's Fiscal Year is From January To December - All Figures are in USD, Billions.

The item "Total-Other-Income-Expense-Net" stands at -1.06 Billion United States Dollars for the trailing twelve months (TTM) period ending 06/30/2026, the lowest value since 03/31/2025.

Johnson & Johnson's second quarter result of -0.427 Billion USD for the item "Total Other Income Expense Net" represents a decrease of -5.43 percent compared to it's first quarter result.

Also, Johnson & Johnson's second quarter result of -0.427 Billion USD for the item "Total Other Income Expense Net" represents a decrease of -33.86 percent compared to it's second quarter result of last year.

Looking again at the trailing twelve months series (TTM), Johnson & Johnson's second quarter result of -1.06 Billion USD for the item "Total Other Income Expense Net" represents a decrease of -11.34 percent compared to it's first quarter result.


Regarding the One-Year-Change of the series, the current value constitutes an decrease of -6.18 Billion United States Dollars compared to the value the year prior.
The 1 year change is -6.18 Billion United States Dollars.
The 3 year change is 7.60 Billion United States Dollars.
The 5 year change is 2.12 Billion United States Dollars.
The 10 year change is 0.046 Billion United States Dollars.

The Serie's long term average value is -2.19 Billion United States Dollars. It's latest available value, on 06/30/2026, is 1.13 Billion United States Dollars higher, compared to it's long term average value.
The Serie's change in United States Dollars from it's minimum value, on 03/31/2023, to it's latest available value, on 06/30/2026, is +8.18 Billion.
The Serie's change in United States Dollars from it's maximum value, on 09/30/2025, to it's latest available value, on 06/30/2026, is -8.52 Billion.

Total Other Income Expense Net for Related Companies:

LogoNameMarket Cap (USD)
LogoEli Lilly and Company - Total Other Income Expense Net905,699,262,464.00
LogoAbbVie Inc - Total Other Income Expense Net399,570,305,024.00
LogoRoche Holding AG - Total Other Income Expense Net317,433,206,677.55
LogoAstraZeneca PLC - Total Other Income Expense Net280,205,508,085.11
LogoNovartis AG - Total Other Income Expense Net255,096,620,580.91